Digoxin Discontinuation in Patients with HFrEF on Beta-Blockers: Implication for Future “Knock-Out Trials” in Heart Failure

By sjmartinez • October 20, 2024

Lam PH, Liu K, Ahmed AA, Butler J, Heidenreich PA, Anker MS, Faselis C, Deedwania P, Aronow WS, Kanonidis I, Masson R, Gill GS, Morgan CJ, Arundel C, Allman RM, Wu WC, Fonarow GC, Ahmed A. Digoxin Discontinuation in Patients with HFrEF on Beta-Blockers: Implication for Future "Knock-Out Trials" in Heart Failure. Am J Med. 2024 Oct 16:S0002-9343(24)00638-7. doi: 10.1016/j.amjmed.2024.10.015. Epub ahead of print. PMID: 39424217.

Tags: beta-blockers, Cardiology/Epi, digoxin, discontinuation, heart failure, HFrEF, Publications

Bioelectronic block of stellate ganglia mitigates pacing-induced heterogeneous release of catecholamine and neuropeptide Y in the infarcted pig heart

Vrabec T, Bender S, Chan SA, Cha S, Haridas S, Hanna P, Ajijola OA, Shivkumar K, Smith C, Ardell JL. Bioelectronic block of stellate ganglia[...]

Atrial Arrhythmias After PFO Device Closure: Common, Clinically Important, and Preventable

Tobis JM, Carroll JD. Atrial Arrhythmias After PFO Device Closure: Common, Clinically Important, and Preventable? Circulation. 2024 Nov 19;150(21):1669-1670. doi: 10.1161/CIRCULATIONAHA.124.071851. Epub 2024 Nov 18.[...]

Early Adoption of Sodium-Glucose Cotransporter-2 Inhibitor in Patients Hospitalized With Heart Failure With Mildly Reduced or Preserved Ejection Fraction

Abdel Jawad M, Spertus JA, Ikeaba U, Greene SJ, Fonarow GC, Chiswell K, Chan PS. Early Adoption of Sodium-Glucose Cotransporter-2 Inhibitor in Patients Hospitalized With[...]